Autoimmune Disorder Drug Delivery Device Market

The exponential rise in the adoption of self-injection devices for the treatment of autoimmune disorders has created a buzz among companies to invest in the development of novel autoimmune disorder drug delivery devices. Due to the leading market products and intense market penetration, Amgen Inc. has been a pioneer in this field and has been a significant competitor in this market.

Autoimmune Disorder Drug Delivery Device Market contains market size and forecasts of Autoimmune Disorder Drug Delivery Device in global, including the following market information:

Global Autoimmune Disorder Drug Delivery Device Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Autoimmune Disorder Drug Delivery Device Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Autoimmune Disorder Drug Delivery Device companies in 2021 (%)

The global Autoimmune Disorder Drug Delivery Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pen Injectors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Autoimmune Disorder Drug Delivery Device include AbbVie Inc., Amgen Inc., F. Hoffmann- La Roche Ltd., Novartis AG, GlaxoSmithKline Plc, Biogen Inc., Merck KGaA, Bayer AG and Johnson & Johnson Services Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Autoimmune Disorder Drug Delivery Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Autoimmune Disorder Drug Delivery Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Autoimmune Disorder Drug Delivery Device Market Segment Percentages, by Type, 2021 (%)

Pen Injectors

Auto-Injectors

Prefilled Syringes

Vials

Global Autoimmune Disorder Drug Delivery Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Autoimmune Disorder Drug Delivery Device Market Segment Percentages, by Application, 2021 (%)

In-house Manufacturing

Outsourced Manufacturing

Global Autoimmune Disorder Drug Delivery Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Autoimmune Disorder Drug Delivery Device Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Autoimmune Disorder Drug Delivery Device revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Autoimmune Disorder Drug Delivery Device revenues share in global market, 2021 (%)

Key companies Autoimmune Disorder Drug Delivery Device sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Autoimmune Disorder Drug Delivery Device sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

AbbVie Inc.

Amgen Inc.

F. Hoffmann- La Roche Ltd.

Novartis AG

GlaxoSmithKline Plc

Biogen Inc.

Merck KGaA

Bayer AG

Johnson & Johnson Services Inc.

Teva Pharmaceutical Industries Ltd.

Eli Lily and Company

Sanofi S.A.

Takeda Pharmaceutical Company Limited